Diagnosis

153 trials 71 recruiting

Filter these 153 trials by phase, country and sponsor.

Open in Search →

A study to learn how gadoquatrane moves into, through, and out of the body and how safe it is in children aged 0 to less than 18 years, who … Ended

2022-501883-17-00 Contrast enhancement in magnetic resonance imaging in c 5 2023-10-16
A study to compare how well gadoquatrane works and its safety with an already available contrast agent for MRI in people with known or suspe… Ended

2022-501884-41-00 Contrast enhancement in magnetic resonance imaging for 5 2023-09-29
A study to compare the effects and safety of gadoquatrane with an already used available contrast agent for MRI tests in people with any kno… Ended

2022-501885-24-00 Contrast enhancement in magnetic resonance imaging for 5 2023-09-20
A Phase 1, Randomized, Double-Blind, Placebo and Positive-Controlled Crossover Study to Evaluate the Effect of Clinical and Supraclinical Do… Ended

2023-504310-30-00 Healthy volunteers 3 2023-08-16
68Ga satoreotide trizoxetan PET/CT in patients with high grade neuroendocrine lung cancer Ended

2023-503362-24-01 large cell neuroendocrine lung cancer 4 2023-08-09
Efficacy of [18F]florbetaben PET for diagnosis of cardiac AL amyloidosis Ended

2022-500186-27-00 ATTR Amyloidosis 5 2023-01-11
Exploratory study evaluating the relevance of [68Ga]Ga-PentixaFor for initial staging and detection of minimal residual disease in multiple … Ended

2022-500339-35-01 Multiple Myeloma 4
Serotonin role on brain circuits involved in food avoidance in anorexia nervosa : Study of Gaze control and multimodal Brain imaging. Ended

2024-519848-33-00 Anorexia Nervosa 5
Clinical use of [18F]florastamine PET/CT in patients with PI-RADS≤3 report of multi-parametric MRI and suspected prostate cancer Ended

2023-510421-14-00 Prostate cancer 5